1 Hyperphosphatemia is probably the most worrisome ... and the consequent retention of phosphorus could be beneficial in kidney transplant recipients, in whom these effects might counterbalance ...

Announced the acceptance of the New Drug Application (NDA) by the U.S. Food and Drug Administration (FDA) for OLC for the treatment of hyperphosphatemia in patients with CKD on dialysis. The FDA set a ...

The kidney is an organ that plays an important role in maintaining the balance of our body. It functions to filter out waste ...

The lead candidate Hyperphosphatemia is a nearly universal condition for patients with chronic kidney disease (CKD) on dialysis, and a major risk factor for cardiovascular morbidity and mortality.

“The approval of tenapanor for hyperphosphatemia in China marks ... guidelines for the diagnosis and treatment of Chronic Kidney Disease Mineral and Bone Disorder, the achievement rate decreases ...

Hyperphosphatemia is a common complication in patients with chronic kidney disease (CKD), caused by phosphate retention as kidney function declines. This condition can result in serious outcomes ...

[5,6,7] Although the idea of a wearable artificial kidney (WAK) is not new ... hyperkalemia, hyperphosphatemia), and also potentially decrease the risk of morbidity and mortality from ...